封面
市場調查報告書
商品編碼
1631223

化妝品用胜肽製造的全球市場 - 全球產業分析,規模,佔有率,成長,趨勢,預測(2032年)

Cosmetic Peptide Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日期: | 出版商: Fairfield Market Research | 英文 224 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

受技術進步、消費者對抗老化解決方案的需求不斷增長以及對永續美容產品的日益關注的推動,化妝品胜肽製造市場正在經歷前所未有的增長。胜肽因其能夠針對衰老、色素沉著和保濕等特定皮膚問題而聞名,已成為現代護膚配方中必不可少的成分。全球化妝品胜肽製造市場規模預計將以 5.6% 的複合年增長率成長,到 2025 年達到 2.47 億美元,到 2032 年達到 3.6177 億美元。推動這一成長的是生物技術的突破,它徹底改變了胜肽的合成,使其能夠精確配製以滿足消費者的需求。

胜肽能夠解決多種皮膚問題,其多功能性使其成為化妝品配方的重要組成部分。隨著消費者偏好的不斷變化和技術進步,化妝品胜肽製造市場將大幅成長。胜肽合成的技術創新,加上個人化和永續皮膚護理的興起,使這個市場成為美容和個人護理行業的變革力量。隨著主要參與者推動技術創新和區域市場提供多樣化機會,該行業有望重新定義現代護膚解決方案。

透過開發源自可再生資源或由可生物降解材料製成的胜肽,製造商可以滿足有環保意識的消費者的需求並利用清潔美容趨勢。南亞和太平洋等地區的快速城市化和可支配收入的增加為市場擴張提供了機會。利用人工智慧護膚分析和數位平台進行產品客製化可以提高消費者的參與度和忠誠度。

本報告提供全球化妝品用胜肽製造市場相關調查,提供市場概要,以及各產品,各用途,最終產品,各終端用戶,及各地區趨勢,及市場參與市場企業的競爭趨勢等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場定義和市場區隔
  • 市場動態
  • 波特的五力分析
  • COVID-19影響分析
  • 烏克蘭·俄羅斯糾紛的影響
  • 經濟概要
  • 大環境分析

第3章 全球化妝品用胜肽製造市場預測,2019年~2032年

  • 全球化妝品用胜肽製造市場預測,各產品,金額(100萬美元),2019年~2032年
  • 全球化妝品用胜肽製造市場預測,各用途,金額(100萬美元),2019年~2032年
  • 全球化妝品用胜肽製造市場預測,最終產品,金額(100萬美元),2019年~2032年
  • 全球化妝品用胜肽製造市場預測,各終端用戶,金額(100萬美元),2019年~2032年
  • 全球化妝品用胜肽製造市場預測,各地區,金額(100萬美元),2019年~2032年

第4章 北美的化妝品用胜肽製造市場預測,2019年~2032年

第5章 歐洲的化妝品用胜肽製造市場預測,2019年~2032年

第6章 亞太地區的化妝品用胜肽製造市場預測,2019年~2032年

第7章 南美的化妝品用胜肽製造市場預測,2019年~2032年

第8章 中東·非洲的化妝品用胜肽製造市場預測,2019年~2032年

第9章 競爭情形

  • 企業市場佔有率分析,2024年
  • 競爭儀表板
  • 企業簡介
    • Croda International plc
    • Merck KGaA
    • USV Private Limited
    • BASF SE
    • CEM Corporation
    • Bachem Holding AG
    • CPC Scientific Inc.
    • Creative Peptides
    • Bio-Synthesis Inc.
    • CSBio China

第10章 附錄

簡介目錄

The cosmetic peptide manufacturing market is experiencing unprecedented growth, fueled by technological advancements, increasing consumer demand for anti-aging solutions, and a rising focus on sustainable beauty products. Peptides, known for their ability to target specific skin concerns such as aging, pigmentation, and hydration, have become essential components in modern skincare formulations. The global cosmetic peptide manufacturing market is projected to grow at a CAGR of 5.6%, reaching a value of USD 247 million by 2025 and USD 361.77 million by 2032. This growth is driven by breakthroughs in biotechnology that have revolutionized the synthesis of peptides, enabling precise formulations tailored to consumer needs

Market Insights

The global cosmetic peptide manufacturing market is projected to grow at a CAGR of 5.6%, reaching a value of USD 247 million by 2025 and USD 361.77 million by 2032. This growth is driven by breakthroughs in biotechnology that have revolutionized the synthesis of peptides, enabling precise formulations tailored to consumer needs. Peptides' versatility in addressing multiple skin concerns has positioned them as indispensable in cosmetic formulations. The cosmetic peptide manufacturing market is poised for substantial growth as it aligns with evolving consumer preferences and technological advancements. Innovations in peptide synthesis, coupled with the rise of personalized and sustainable skincare, position this market as a transformative force in the beauty and personal care industry. With key players driving innovation and regional markets presenting diverse opportunities, the industry is set to redefine modern skincare solutions.

Drivers of Growth

  • 1. Advances in Biotechnology: Innovative techniques such as solid-phase peptide synthesis and recombinant DNA technology have enhanced the efficiency and specificity of peptide production, enabling the development of cutting-edge skincare solutions.
  • 2. Rising Demand for Anti-Aging Products: Consumers increasingly seek products that address visible signs of aging, such as wrinkles and fine lines. Peptides, known for stimulating collagen production and promoting skin elasticity, are at the forefront of this trend.
  • 3. Sustainability and Clean Beauty Movement: The growing emphasis on sustainable and eco-friendly beauty solutions has prompted manufacturers to develop green peptide formulations, aligning with consumer preferences for environmentally conscious products.
  • 4. Personalized Skincare: Advances in technology have enabled personalized skincare solutions, allowing manufacturers to create bespoke peptide formulations tailored to individual needs, further driving market growth.

Business Opportunities

  • 1. Sustainable Peptide Formulations: Manufacturers can capitalize on the clean beauty trend by developing peptides derived from renewable resources or utilizing biodegradable materials, catering to environmentally conscious consumers.
  • 2. Expansion into Emerging Markets: Rapid urbanization and increasing disposable income in regions such as South Asia and the Pacific present lucrative opportunities for market expansion.
  • 3. Integration of AI and Digital Technologies: Leveraging AI-driven skincare analysis and digital platforms for product customization can enhance consumer engagement and loyalty.

Regional Analysis

  • 1. Europe: The Market Leader Europe dominates the cosmetic peptide manufacturing market due to its advanced industry infrastructure, stringent regulatory standards, and strong R&D capabilities. The region's focus on premium beauty products further bolsters its leadership position.
  • 2. South Asia & Pacific: A Rapidly Growing Market With a thriving beauty and personal care industry, the South Asia & Pacific region is witnessing accelerated growth. Factors such as an aging population, rising skincare awareness, and advancements in healthcare infrastructure contribute to this region's market expansion.

Key Players Prominent companies driving innovation and market growth include:

  • Croda International Plc
  • Ashland
  • DSM (Koninklijke DSM NV)
  • Bachem
  • Genscript Biotech Corp
  • BASF SE
  • Geltor
  • The Lubrizol Corporation
  • Symrise
  • Bio Basic Inc.
  • Regeron Inc.

Market Segmentation The cosmetic peptide manufacturing market is segmented based on product type, application, end-user, and region.

1. By Product Type:

    Signal Peptides Neurotransmitter Inhibitors Carrier Peptides Enzyme Inhibitor Peptides Structural Peptides Synthetic Antimicrobial Peptides (AMPs) Others

2. By Application:

    Anti-Aging Eye Care Anti-Pigmentation Hair Growth

3. By End User:

    Cosmetic Manufacturers Cosmetic Contract Manufacturers Biopharmaceutical Industries (Personal Care)

4. By Region:

    North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cosmetic Peptide Manufacturing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Porter's Five Forces Analysis
  • 2.4. COVID-19 Impact Analysis
    • 2.4.1. Supply
    • 2.4.2. Demand
  • 2.5. Impact of Ukraine-Russia Conflict
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. Global Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 3.1. Global Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Neurotransmitter Inhibitors
      • 3.1.1.2. Enzyme Inhibitor Peptides
      • 3.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 3.1.1.4. Signal Peptides
      • 3.1.1.5. Carrier Peptides
      • 3.1.1.6. Others
  • 3.2. Global Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Whitening
      • 3.2.1.2. Anti-Aging
      • 3.2.1.3. Hair/Eyecare/Eyelash Care
      • 3.2.1.4. Slimming & Breast Enhancement
      • 3.2.1.5. Others
  • 3.3. Global Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Skin Care
        • 3.3.1.1.1. Sunscreen Lotion
        • 3.3.1.1.2. Serum
        • 3.3.1.1.3. Creams and Moisturizers
      • 3.3.1.2. Eye Care
        • 3.3.1.2.1. Serum
        • 3.3.1.2.2. Cream
      • 3.3.1.3. Hair Care
        • 3.3.1.3.1. Serum
        • 3.3.1.3.2. Cream
      • 3.3.1.4. Others
  • 3.4. Global Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. Cosmetic Manufacturers
      • 3.4.1.2. Cosmetic Contract Manufacturers
      • 3.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 3.5. Global Cosmetic Peptide Manufacturing Market Outlook, by Region, Value (US$ Mn), 2019 - 2032
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 4.1. North America Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Neurotransmitter Inhibitors
      • 4.1.1.2. Enzyme Inhibitor Peptides
      • 4.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 4.1.1.4. Signal Peptides
      • 4.1.1.5. Carrier Peptides
      • 4.1.1.6. Others
  • 4.2. North America Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Whitening
      • 4.2.1.2. Anti-Aging
      • 4.2.1.3. Hair/Eyecare/Eyelash Care
      • 4.2.1.4. Slimming & Breast Enhancement
      • 4.2.1.5. Others
  • 4.3. North America Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Skin Care
        • 4.3.1.1.1. Sunscreen Lotion
        • 4.3.1.1.2. Serum
        • 4.3.1.1.3. Creams and Moisturizers
      • 4.3.1.2. Eye Care
        • 4.3.1.2.1. Serum
        • 4.3.1.2.2. Cream
      • 4.3.1.3. Hair Care
        • 4.3.1.3.1. Serum
        • 4.3.1.3.2. Cream
      • 4.3.1.4. Others
  • 4.4. North America Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Cosmetic Manufacturers
      • 4.4.1.2. Cosmetic Contract Manufacturers
      • 4.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 4.5. North America Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.2. U.S. Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 4.5.1.3. U.S. Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.4. U.S. Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 4.5.1.5. Canada Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.6. Canada Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 4.5.1.7. Canada Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.8. Canada Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 5.1. Europe Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Neurotransmitter Inhibitors
      • 5.1.1.2. Enzyme Inhibitor Peptides
      • 5.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 5.1.1.4. Signal Peptides
      • 5.1.1.5. Carrier Peptides
      • 5.1.1.6. Others
  • 5.2. Europe Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Whitening
      • 5.2.1.2. Anti-Aging
      • 5.2.1.3. Hair/Eyecare/Eyelash Care
      • 5.2.1.4. Slimming & Breast Enhancement
      • 5.2.1.5. Others
  • 5.3. Europe Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Skin Care
        • 5.3.1.1.1. Sunscreen Lotion
        • 5.3.1.1.2. Serum
        • 5.3.1.1.3. Creams and Moisturizers
      • 5.3.1.2. Eye Care
        • 5.3.1.2.1. Serum
        • 5.3.1.2.2. Cream
      • 5.3.1.3. Hair Care
        • 5.3.1.3.1. Serum
        • 5.3.1.3.2. Cream
      • 5.3.1.4. Others
  • 5.4. Europe Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Cosmetic Manufacturers
      • 5.4.1.2. Cosmetic Contract Manufacturers
      • 5.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 5.5. Europe Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.2. Germany Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.3. Germany Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.4. Germany Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.5. U.K. Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.6. U.K. Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.7. U.K. Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.8. U.K. Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.9. France Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.10. France Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.11. France Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.12. France Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.13. Italy Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.14. Italy Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.15. Italy Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.16. Italy Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.17. Turkey Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.18. Turkey Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.19. Turkey Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.20. Turkey Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.21. Russia Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.22. Russia Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.23. Russia Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.24. Russia Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.25. Rest of Europe Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.26. Rest of Europe Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.27. Rest of Europe Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.28. Rest of Europe Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Neurotransmitter Inhibitors
      • 6.1.1.2. Enzyme Inhibitor Peptides
      • 6.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 6.1.1.4. Signal Peptides
      • 6.1.1.5. Carrier Peptides
      • 6.1.1.6. Others
  • 6.2. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Whitening
      • 6.2.1.2. Anti-Aging
      • 6.2.1.3. Hair/Eyecare/Eyelash Care
      • 6.2.1.4. Slimming & Breast Enhancement
      • 6.2.1.5. Others
  • 6.3. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Skin Care
        • 6.3.1.1.1. Sunscreen Lotion
        • 6.3.1.1.2. Serum
        • 6.3.1.1.3. Creams and Moisturizers
      • 6.3.1.2. Eye Care
        • 6.3.1.2.1. Serum
        • 6.3.1.2.2. Cream
      • 6.3.1.3. Hair Care
        • 6.3.1.3.1. Serum
        • 6.3.1.3.2. Cream
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Cosmetic Manufacturers
      • 6.4.1.2. Cosmetic Contract Manufacturers
      • 6.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 6.5. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.2. China Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.3. China Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.4. China Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.5. Japan Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.6. Japan Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.7. Japan Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.8. Japan Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.9. South Korea Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.10. South Korea Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.11. South Korea Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.12. South Korea Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.13. India Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.14. India Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.15. India Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.16. India Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.17. Southeast Asia Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.18. Southeast Asia Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.19. Southeast Asia Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.20. Southeast Asia Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.21. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.22. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.23. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.24. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 7.1. Latin America Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Neurotransmitter Inhibitors
      • 7.1.1.2. Enzyme Inhibitor Peptides
      • 7.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 7.1.1.4. Signal Peptides
      • 7.1.1.5. Carrier Peptides
      • 7.1.1.6. Others
  • 7.2. Latin America Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Whitening
      • 7.2.1.2. Anti-Aging
      • 7.2.1.3. Hair/Eyecare/Eyelash Care
      • 7.2.1.4. Slimming & Breast Enhancement
      • 7.2.1.5. Others
  • 7.3. Latin America Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Skin Care
        • 7.3.1.1.1. Sunscreen Lotion
        • 7.3.1.1.2. Serum
        • 7.3.1.1.3. Creams and Moisturizers
      • 7.3.1.2. Eye Care
        • 7.3.1.2.1. Serum
        • 7.3.1.2.2. Cream
      • 7.3.1.3. Hair Care
        • 7.3.1.3.1. Serum
        • 7.3.1.3.2. Cream
      • 7.3.1.4. Others
  • 7.4. Latin America Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Cosmetic Manufacturers
      • 7.4.1.2. Cosmetic Contract Manufacturers
      • 7.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 7.5. Latin America Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.2. Brazil Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.3. Brazil Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.4. Brazil Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.5. Mexico Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.6. Mexico Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.7. Mexico Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.8. Mexico Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.9. Argentina Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.10. Argentina Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.11. Argentina Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.12. Argentina Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.13. Rest of Latin America Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.14. Rest of Latin America Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.15. Rest of Latin America Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.16. Rest of Latin America Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Neurotransmitter Inhibitors
      • 8.1.1.2. Enzyme Inhibitor Peptides
      • 8.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 8.1.1.4. Signal Peptides
      • 8.1.1.5. Carrier Peptides
      • 8.1.1.6. Others
  • 8.2. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Whitening
      • 8.2.1.2. Anti-Aging
      • 8.2.1.3. Hair/Eyecare/Eyelash Care
      • 8.2.1.4. Slimming & Breast Enhancement
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Skin Care
        • 8.3.1.1.1. Sunscreen Lotion
        • 8.3.1.1.2. Serum
        • 8.3.1.1.3. Creams and Moisturizers
      • 8.3.1.2. Eye Care
        • 8.3.1.2.1. Serum
        • 8.3.1.2.2. Cream
      • 8.3.1.3. Hair Care
        • 8.3.1.3.1. Serum
        • 8.3.1.3.2. Cream
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Cosmetic Manufacturers
      • 8.4.1.2. Cosmetic Contract Manufacturers
      • 8.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 8.5. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.2. GCC Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.3. GCC Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.4. GCC Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.5. South Africa Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.6. South Africa Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.7. South Africa Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.8. South Africa Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.9. Egypt Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.10. Egypt Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.11. Egypt Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.12. Egypt Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.13. Nigeria Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.14. Nigeria Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.15. Nigeria Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.16. Nigeria Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.17. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.18. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.19. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.20. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2024
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Croda International plc
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Merck KGaA
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. USV Private Limited
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. BASF SE
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. CEM Corporation
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Bachem Holding AG
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. CPC Scientific Inc.
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Creative Peptides
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Bio-Synthesis Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. CSBio China
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Product Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations